Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1,800,000 Profiles
More than 3,500 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Harold Moses

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.8 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Disorders

Neoplastic Cell Transformation

Phenomena

Northern Blotting

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
24
Chytil, Anna
19
Gorska, Agnieszka
15
Aakre, Mary
14
Coffey, Robert
13
Bhowmick, Neil
13
Pietenpol, Jennifer
12
Bierie, Brian
9
Arteaga, Carlos
9
Law, Brian
8
Derynck, Rik
8
Shyr, Yu
7
Beauchamp, Daniel
7
Datta, Pran
5
Brown, Kimberly
5
Serra, Rosa

Sign-in to see all Coauthors

Publications

TOP 3
Bierie Brian; Moses Harold L
Transforming growth factor beta (TGF-beta) and inflammation in cancer.
Matise Lauren A; Pickup Michael W; Moses Harold L
TGF-beta helps cells fly solo.
Bierie Brian; Moses Harold L
Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Harold Moses (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2010: Bierie Brian; Moses Harold L
Transforming growth factor beta (TGF-beta) and inflammation in cancer.
Cytokine & growth factor reviews 2010;21(1):49-59.
2009: Matise Lauren A; Pickup Michael W; Moses Harold L
TGF-beta helps cells fly solo.
Nature cell biology 2009;11(11):1281-4.
2009: Bierie Brian; Moses Harold L
Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis.
Cell cycle (Georgetown, Tex.) 2009;8(20):3319-27.
2009: Bierie Brian; Chung Christine H; Parker Joel S; Stover Daniel G; Cheng Nikki; Chytil Anna; Aakre Mary; Shyr Yu; Moses Harold L
Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.
The Journal of clinical investigation 2009;119(6):1571-82.
2009: Abel Ty W; Clark Cara; Bierie Brian; Chytil Anna; Aakre Mary; Gorska Agnieszka; Moses Harold L
GFAP-Cre-mediated activation of oncogenic K-ras results in expansion of the subventricular zone and infiltrating glioma.
Molecular cancer research : MCR 2009;7(5):645-53.
2009: Bierie Brian; Gorska Agnieszka E; Stover Daniel G; Moses Harold L
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution.
Journal of cellular physiology 2009;219(1):57-68.
2008: Yang Li; Moses Harold L
Transforming growth factor beta: tumor suppressor or promoter? Are host immune cells the answer?
Cancer research 2008;68(22):9107-11.
2008: Erdogan Mete; Pozzi Ambra; Bhowmick Neil; Moses Harold L; Zent Roy
Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells.
Cancer research 2008;68(15):6224-31.
2008: Bierie Brian; Stover Daniel G; Abel Ty W; Chytil Anna; Gorska Agnieszka E; Aakre Mary; Forrester Elizabeth; Yang Li; Wagner Kay-Uwe; Moses Harold L
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
Cancer research 2008;68(6):1809-19.
2008: Yang Li; Huang Jianhua; Ren Xiubao; Gorska Agnieszka E; Chytil Anna; Aakre Mary; Carbone David P; Matrisian Lynn M; Richmond Ann; Lin P Charles; Moses Harold L
Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis.
Cancer cell 2008;13(1):23-35.
2007: Erdogan Mete; Pozzi Ambra; Bhowmick Neil; Moses Harold L; Zent Roy
Signaling pathways regulating TC21-induced tumorigenesis.
The Journal of biological chemistry 2007;282(38):27713-20.
2007: Stover Daniel G; Bierie Brian; Moses Harold L
A delicate balance: TGF-beta and the tumor microenvironment.
Journal of cellular biochemistry 2007;101(4):851-61.
2007: Spagnoli Anna; O'Rear Lynda; Chandler Ronald L; Granero-Molto Froilan; Mortlock Douglas P; Gorska Agnieszka E; Weis Jared A; Longobardi Lara; Chytil Anna; Shimer Kimberly; Moses Harold L
TGF-beta signaling is essential for joint morphogenesis.
The Journal of cell biology 2007;177(6):1105-17.
2007: Cheng Nikki; Chytil Anna; Shyr Yu; Joly Alison; Moses Harold L
Enhanced hepatocyte growth factor signaling by type II transforming growth factor-beta receptor knockout fibroblasts promotes mammary tumorigenesis.
Cancer research 2007;67(10):4869-77.
2007: Biswas Swati; Guix Marta; Rinehart Cammie; Dugger Teresa C; Chytil Anna; Moses Harold L; Freeman Michael L; Arteaga Carlos L
Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.
The Journal of clinical investigation 2007;117(5):1305-13.
2007: Brown Kimberly A; Pietenpol Jennifer A; Moses Harold L
A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling.
Journal of cellular biochemistry 2007;101(1):9-33.
2007: Bonine-Summers Alyssa R; Aakre Mary E; Brown Kimberly A; Arteaga Carlos L; Pietenpol Jennifer A; Moses Harold L; Cheng Nikki
Epidermal growth factor receptor plays a significant role in hepatocyte growth factor mediated biological responses in mammary epithelial cells.
Cancer biology & therapy 2007;6(4):561-70.
2007: Harper Elizabeth; Moses Harold; Lagrange Andre
Occult celiac disease presenting as epilepsy and MRI changes that responded to gluten-free diet.
Neurology 2007;68(7):533-4.
2007: Labbé Etienne; Lock Lisa; Letamendia Ainhoa; Gorska Agnieszka E; Gryfe Robert; Gallinger Steven; Moses Harold L; Attisano Liliana
Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis.
Cancer research 2007;67(1):75-84.
2007: Hoshino Arichika; Yee Cindy J; Campbell Mel; Woltjer Randall L; Townsend Rebecca L; van der Meer Riet; Shyr Yu; Holt Jeffrey T; Moses Harold L; Jensen Roy A
Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
International journal of biological sciences 2007;3(5):281-91.
2006: Ijichi Hideaki; Chytil Anna; Gorska Agnieszka E; Aakre Mary E; Fujitani Yoshio; Fujitani Shuko; Wright Christopher V E; Moses Harold L
Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Genes & development 2006;20(22):3147-60.
2006: Muñoz Nina M; Upton Melissa; Rojas Andres; Washington M Kay; Lin Li; Chytil Anna; Sozmen Elif G; Madison Blair B; Pozzi Ambra; Moon Randall T; Moses Harold L; Grady William M
Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
Cancer research 2006;66(20):9837-44.
2006: Bierie Brian; Moses Harold L
Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Nature reviews. Cancer 2006;6(7):506-20.
2006: Halder Sunil K; Anumanthan Govindaraj; Maddula Ramakoti; Mann Jason; Chytil Anna; Gonzalez Adriana L; Washington M Key; Moses Harold L; Beauchamp R Daniel; Datta Pran K
Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis.
Cancer research 2006;66(12):6156-66.
2006: Longobardi Lara; O'Rear Lynda; Aakula Srikanth; Johnstone Brian; Shimer Kimberly; Chytil Anna; Horton William A; Moses Harold L; Spagnoli Anna
Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(4):626-36.
2006: Bierie Brian; Moses Harold L
TGF-beta and cancer.
Cytokine & growth factor reviews 2006;17(1-2):29-40.
2005: Bierie Brian; Moses Harold L
Under pressure: stromal fibroblasts change their ways.
Cell 2005;123(6):985-7.
2005: Xie Lu; Xu Baogang J; Gorska Agnieszka E; Shyr Yu; Schwartz Sarah A; Cheng Nikki; Levy Shawn; Bierie Brian; Caprioli Richard M; Moses Harold L
Genomic and proteomic analysis of mammary tumors arising in transgenic mice.
Journal of proteome research 2005;4(6):2088-98.
2005: Cheng Nikki; Bhowmick Neil A; Chytil Anna; Gorksa Agnieszka E; Brown Kimberly A; Muraoka Rebecca; Arteaga Carlos L; Neilson Eric G; Hayward Simon W; Moses Harold L
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
Oncogene 2005;24(32):5053-68.
2005: O'Rear L; Longobardi L; Torello M; Law B K; Moses H L; Chiarelli F; Spagnoli A
Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
Journal of molecular endocrinology 2005;34(3):723-37.
2005: Means Anna L; Chytil Anna; Moses Harold L; Coffey Robert J; Wright Christopher V E; Taketo Makoto M; Grady William M
Keratin 19 gene drives Cre recombinase expression throughout the early postimplantation mouse embryo.
Genesis (New York, N.Y. : 2000) 2005;42(1):23-7.
2005: Desgrosellier Jay S; Mundell Nathan A; McDonnell Maureen A; Moses Harold L; Barnett Joey V
Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation.
Developmental biology 2005;280(1):201-10.
2005: Romero-Gallo Judith; Sozmen Elif G; Chytil Anna; Russell William E; Whitehead Robert; Parks W Tony; Holdren Matthew S; Her Momoko F; Gautam Shiva; Magnuson Mark; Moses Harold L; Grady William M
Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy.
Oncogene 2005;24(18):3028-41.
2005: Forrester Elizabeth; Chytil Anna; Bierie Brian; Aakre Mary; Gorska Agnieszka E; Sharif-Afshar Ali-Reza; Muller William J; Moses Harold L
Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Cancer research 2005;65(6):2296-302.
2005: Bhowmick Neil A; Moses Harold L
Tumor-stroma interactions.
Current opinion in genetics & development 2005;15(1):97-101.
2004: Baffi Michael O; Slattery Erin; Sohn Philip; Moses Harold L; Chytil Anna; Serra Rosa
Conditional deletion of the TGF-beta type II receptor in Col2a expressing cells results in defects in the axial skeleton without alterations in chondrocyte differentiation or embryonic development of long bones.
Developmental biology 2004;276(1):124-42.
2004: Bhowmick Neil A; Neilson Eric G; Moses Harold L
Stromal fibroblasts in cancer initiation and progression.
Nature 2004;432(7015):332-7.
2004: Xie Lu; Law Brian K; Chytil Anna M; Brown Kimberly A; Aakre Mary E; Moses Harold L
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro.
Neoplasia (New York, N.Y.) 2004;6(5):603-10.
2004: Biswas Swati; Chytil Anna; Washington Kay; Romero-Gallo Judith; Gorska Agnieszka E; Wirth Pamela S; Gautam Shiva; Moses Harold L; Grady William M
Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
Cancer research 2004;64(14):4687-92.
2004: Weitkamp Joern-Hendrik; Spring Michelle Donna; Brogan Terrance; Moses Harold; Bloch Karen C; Wright Peter Farnum
Influenza A virus-associated acute necrotizing encephalopathy in the United States.
The Pediatric infectious disease journal 2004;23(3):259-63.
2004: Bhowmick Neil A; Chytil Anna; Plieth David; Gorska Agnieszka E; Dumont Nancy; Shappell Scott; Washington M Kay; Neilson Eric G; Moses Harold L
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia.
Science (New York, N.Y.) 2004;303(5659):848-51.
2004: Beebe David; Garcia Claudia; Wang Xiaohui; Rajagopal Ramya; Feldmeier Mary; Kim Ji-Young; Chytil Anna; Moses Harold; Ashery-Padan Ruth; Rauchman Michael
Contributions by members of the TGFbeta superfamily to lens development.
The International journal of developmental biology 2004;48(8-9):845-56.
2004: Brown Kimberly A; Aakre Mary E; Gorska Agnieska E; Price James O; Eltom Sakina E; Pietenpol Jennifer A; Moses Harold L
Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro.
Breast cancer research : BCR 2004;6(3):R215-31.
2003: Bhowmick Neil A; Ghiassi Mayshan; Aakre Mary; Brown Kimberly; Singh Vikas; Moses Harold L
TGF-beta-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(26):15548-53.
2003: Muraoka Rebecca S; Koh Yasuhiro; Roebuck L Renee; Sanders Melinda E; Brantley-Sieders Dana; Gorska Agnieszka E; Moses Harold L; Arteaga Carlos L
Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1.
Molecular and cellular biology 2003;23(23):8691-703.
2003: Ito Yoshihiro; Yeo Jae Yong; Chytil Anna; Han Jun; Bringas Pablo; Nakajima Akira; Shuler Charles F; Moses Harold L; Chai Yang
Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects.
Development (Cambridge, England) 2003;130(21):5269-80.
2003: Gorska Agnieszka E; Jensen Roy A; Shyr Yu; Aakre Mary E; Bhowmick Neil A; Moses Harold L
Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation.
The American journal of pathology 2003;163(4):1539-49.
2003: Tu William H; Thomas Tania Z; Masumori Naoya; Bhowmick Neil A; Gorska Agnieszka E; Shyr Yu; Kasper Susan; Case Tom; Roberts Richard L; Shappell Scott B; Moses Harold L; Matusik Robert J
The loss of TGF-beta signaling promotes prostate cancer metastasis.
Neoplasia (New York, N.Y.) 2003;5(3):267-77.
2003: Xie Lu; Law Brian K; Aakre Mary E; Edgerton Mary; Shyr Yu; Bhowmick Neil A; Moses Harold L
Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line.
Breast cancer research : BCR 2003;5(6):R187-98.
2002: Law Brian K; Chytil Anna; Dumont Nancy; Hamilton Elizabeth G; Waltner-Law Mary E; Aakre Mary E; Covington Cassondra; Moses Harold L
Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells.
Molecular and cellular biology 2002;22(23):8184-98.
2002: Glaser Keith B; Li Junling; Aakre Mary E; Morgan Douglas W; Sheppard George; Stewart Kent D; Pollock Jennifer; Lee Paul; O'Connor Chad Z; Anderson Steven N; Mussatto Donna J; Wegner Craig W; Moses Harold L
Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase.
Molecular cancer therapeutics 2002;1(10):759-68.
2002: Chytil Anna; Magnuson Mark A; Wright Christopher V E; Moses Harold L
Conditional inactivation of the TGF-beta type II receptor using Cre:Lox.
Genesis (New York, N.Y. : 2000) 2002;32(2):73-5.
2001: Bhowmick N A; Zent R; Ghiassi M; McDonnell M; Moses H L
Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
The Journal of biological chemistry 2001;276(50):46707-13.
2001: Bragg A D; Moses H L; Serra R
Signaling to the epithelium is not sufficient to mediate all of the effects of transforming growth factor beta and bone morphogenetic protein 4 on murine embryonic lung development.
Mechanisms of development 2001;109(1):13-26.
2001: Satterwhite D J; White R L; Aakre M E; Moses H L
TGF-beta1 regulates the expression of multiple max-interacting transcription factors in Balb/MK cells: implications for understanding the mechanism of action of TGF-beta1.
Pediatric research 2001;50(1):67-75.
2001: McDonnell M A; Law B K; Serra R; Moses H L
Antagonistic effects of TGFbeta1 and BMP-6 on skin keratinocyte differentiation.
Experimental cell research 2001;263(2):265-73.
2001: Bhowmick N A; Ghiassi M; Bakin A; Aakre M; Lundquist C A; Engel M E; Arteaga C L; Moses H L
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism.
Molecular biology of the cell 2001;12(1):27-36.
2001: Entingh A J; Law B K; Moses H L
Induction of the C/EBP homologous protein (CHOP) by amino acid deprivation requires insulin-like growth factor I, phosphatidylinositol 3-kinase, and mammalian target of rapamycin signaling.
Endocrinology 2001;142(1):221-8.
2000: Datta P K; Blake M C; Moses H L
Regulation of plasminogen activator inhibitor-1 expression by transforming growth factor-beta -induced physical and functional interactions between smads and Sp1.
The Journal of biological chemistry 2000;275(51):40014-9.
2000: Law B K; Waltner-Law M E; Entingh A J; Chytil A; Aakre M E; Nørgaard P; Moses H L
Salicylate-induced growth arrest is associated with inhibition of p70s6k and down-regulation of c-myc, cyclin D1, cyclin A, and proliferating cell nuclear antigen.
The Journal of biological chemistry 2000;275(49):38261-7.
2000: Bakin A V; Tomlinson A K; Bhowmick N A; Moses H L; Arteaga C L
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.
The Journal of biological chemistry 2000;275(47):36803-10.
2000: Datta P K; Moses H L
STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
Molecular and cellular biology 2000;20(9):3157-67.
1999: Saha D; Datta P K; Sheng H; Morrow J D; Wada M; Moses H L; Beauchamp R D
Synergistic induction of cyclooxygenase-2 by transforming growth factor-beta1 and epidermal growth factor inhibits apoptosis in epithelial cells.
Neoplasia (New York, N.Y.) 1999;1(6):508-17.
1999: Engel M E; McDonnell M A; Law B K; Moses H L
Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription.
The Journal of biological chemistry 1999;274(52):37413-20.
1999: Joseph H; Gorska A E; Sohn P; Moses H L; Serra R
Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.
Molecular biology of the cell 1999;10(4):1221-34.
1999: Hougaard S; Nørgaard P; Abrahamsen N; Moses H L; Spang-Thomsen M; Skovgaard Poulsen H
Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
British journal of cancer 1999;79(7-8):1005-11.
1999: Law B K; Nørgaard P; Gnudi L; Kahn B B; Poulson H S; Moses H L
Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway.
The Journal of biological chemistry 1999;274(8):4743-8.
1999: Nørgaard P; Law B; Joseph H; Page D L; Shyr Y; Mays D; Pietenpol J A; Kohl N E; Oliff A; Coffey R J; Poulsen H S; Moses H L
Treatment with farnesyl-protein transferase inhibitor induces regression of mammary tumors in transforming growth factor (TGF) alpha and TGF alpha/neu transgenic mice by inhibition of mitogenic activity and induction of apoptosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(1):35-42.
1999: Nørgaard P; Law B K; Plovisson H S; Moses H L
Farnesyltransferase inhibitor-induced regression of mammary tumors in TGF alpha and TGF alpha/neu transgenic mice correlates with inhibition of map kinase and p70s6 kinase phosphorylation.
Annals of the New York Academy of Sciences 1999;886():265-8.
1998: Datta P K; Chytil A; Gorska A E; Moses H L
Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling.
The Journal of biological chemistry 1998;273(52):34671-4.
1998: Alexandrow M G; Moses H L
c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Journal of cellular biochemistry 1998;70(4):528-42.
1998: Engel M E; Datta P K; Moses H L
RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation.
The Journal of biological chemistry 1998;273(16):9921-6.
1998: Gorska A E; Joseph H; Derynck R; Moses H L; Serra R
Dominant-negative interference of the transforming growth factor beta type II receptor in mammary gland epithelium results in alveolar hyperplasia and differentiation in virgin mice.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1998;9(3):229-38.
1998: Engel M E; Datta P K; Moses H L
Signal transduction by transforming growth factor-beta: a cooperative paradigm with extensive negative regulation.
Journal of cellular biochemistry. Supplement 1998;30-31():111-22.
1997: Serra R; Johnson M; Filvaroff E H; LaBorde J; Sheehan D M; Derynck R; Moses H L
Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis.
The Journal of cell biology 1997;139(2):541-52.
1997: Alexandrow M G; Moses H L
Kips off to Myc: implications for TGF beta signaling.
Journal of cellular biochemistry 1997;66(4):427-32.
1995: Alexandrow M G; Moses H L
Transforming growth factor beta 1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription.
Cancer research 1995;55(17):3928-32.
1995: Serra R; Moses H L
pRb is necessary for inhibition of N-myc expression by TGF-beta 1 in embryonic lung organ cultures.
Development (Cambridge, England) 1995;121(9):3057-66.
1995: Pierce D F; Gorska A E; Chytil A; Meise K S; Page D L; Coffey R J; Moses H L
Mammary tumor suppression by transforming growth factor beta 1 transgene expression.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(10):4254-8.
1995: Alexandrow M G; Kawabata M; Aakre M; Moses H L
Overexpression of the c-Myc oncoprotein blocks the growth-inhibitory response but is required for the mitogenic effects of transforming growth factor beta 1.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(8):3239-43.
1995: Kawabata M; Chytil A; Moses H L
Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor.
The Journal of biological chemistry 1995;270(10):5625-30.
1995: Dagnino L; Zhu L; Skorecki K L; Moses H L
E2F-independent transcriptional repression by p107, a member of the retinoblastoma family of proteins.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(2):191-8.
1994: Satterwhite D J; Aakre M E; Gorska A E; Moses H L
Inhibition of cell growth by TGF beta 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1994;5(8):789-99.
1994: Serra R; Pelton R W; Moses H L
TGF beta 1 inhibits branching morphogenesis and N-myc expression in lung bud organ cultures.
Development (Cambridge, England) 1994;120(8):2153-61.
1994: Moses H L; Arteaga C L; Alexandrow M G; Dagnino L; Kawabata M; Pierce D F; Serra R
TGF beta regulation of cell proliferation.
Princess Takamatsu symposia 1994;24():250-63.
1993: Pierce D F; Johnson M D; Matsui Y; Robinson S D; Gold L I; Purchio A F; Daniel C W; Hogan B L; Moses H L
Inhibition of mammary duct development but not alveolar outgrowth during pregnancy in transgenic mice expressing active TGF-beta 1.
Genes & development 1993;7(12A):2308-17.
1993: Johnson M D; Jennings M T; Gold L I; Moses H L
Transforming growth factor-beta in neural embryogenesis and neoplasia.
Human pathology 1993;24(5):457-62.
1993: Arteaga C L; Carty-Dugger T; Moses H L; Hurd S D; Pietenpol J A
Transforming growth factor beta 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic mice.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(3):193-201.
1993: Dagnino L; Pietenpol J A; Yang E Y; Moses H L
Transforming growth factor regulation of keratinocyte growth.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;128():15-29.
1992: Johnson M D; Gold L I; Moses H L
Evidence for transforming growth factor-beta expression in human leptomeningeal cells and transforming growth factor-beta-like activity in human cerebrospinal fluid.
Laboratory investigation; a journal of technical methods and pathology 1992;67(3):360-8.
1992: Moses H L
TGF-beta regulation of epithelial cell proliferation.
Molecular reproduction and development 1992;32(2):179-84.
1992: Beauchamp R D; Sheng H M; Bascom C C; Miller D A; Lyons R M; Torre-Amione G; Moses H L
Phenotypic alterations in fibroblasts and fibrosarcoma cells that overexpress latent transforming growth factor-beta 1.
Endocrinology 1992;130(5):2476-86.
1991: Pelton R W; Johnson M D; Perkett E A; Gold L I; Moses H L
Expression of transforming growth factor-beta 1, -beta 2, and -beta 3 mRNA and protein in the murine lung.
American journal of respiratory cell and molecular biology 1991;5(6):522-30.
1991: Barnard J A; Polk W H; Moses H L; Coffey R J
Production of transforming growth factor-alpha by normal rat small intestine.
The American journal of physiology 1991;261(6 Pt 1):C994-1000.
1991: Lyons R M; Miller D A; Graycar J L; Moses H L; Derynck R
Differential binding of transforming growth factor-beta 1, -beta 2, and -beta 3 by fibroblasts and epithelial cells measured by affinity cross-linking of cell surface receptors.
Molecular endocrinology (Baltimore, Md.) 1991;5(12):1887-96.
1991: Pelton R W; Saxena B; Jones M; Moses H L; Gold L I
Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development.
The Journal of cell biology 1991;115(4):1091-105.
1991: Pietenpol J A; Münger K; Howley P M; Stein R W; Moses H L
Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(22):10227-31.
1991: Beauchamp R D; Coffey R J; Lyons R M; Perkett E A; Townsend C M; Moses H L
Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth.
Cancer research 1991;51(19):5253-60.
1991: Schwartz H S; Butler M G; Jenkins R B; Miller D A; Moses H L
Telomeric associations and consistent growth factor overexpression detected in giant cell tumor of bone.
Cancer genetics and cytogenetics 1991;56(2):263-76.
1991: Jennings M T; Maciunas R J; Carver R; Bascom C C; Juneau P; Misulis K; Moses H L
TGF beta 1 and TGF beta 2 are potential growth regulators for low-grade and malignant gliomas in vitro: evidence in support of an autocrine hypothesis.
International journal of cancer. Journal international du cancer 1991;49(1):129-39.
1991: Moses H L; Yang E Y; Pietenpol J A
Regulation of epithelial proliferation by TGF-beta.
Ciba Foundation symposium 1991;157():66-74; discussion 75-80.
1991: Moses H L; Pietenpol J A; Münger K; Murphy C S; Yang E Y
TGF beta regulation of epithelial cell proliferation: role of tumor suppressor genes.
Princess Takamatsu symposia 1991;22():183-95.
1991: Murphy C S; Pietenpol J A; Münger K; Howley P M; Moses H L
c-myc and pRB: role in TGF-beta 1 inhibition of keratinocyte proliferation.
Cold Spring Harbor symposia on quantitative biology 1991;56():129-35.
1990: Pelton R W; Moses H L
The beta-type transforming growth factor. Mediators of cell regulation in the lung.
The American review of respiratory disease 1990;142(6 Pt 2):S31-5.
1990: Perkett E A; Lyons R M; Moses H L; Brigham K L; Meyrick B
Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.
The Journal of clinical investigation 1990;86(5):1459-64.
1990: Fava R A; Casey T T; Wilcox J; Pelton R W; Moses H L; Nanney L B
Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules.
Blood 1990;76(10):1946-55.
1990: Moses H L; Yang E Y; Pietenpol J A
TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.
Cell 1990;63(2):245-7.
1990: Pelton R W; Dickinson M E; Moses H L; Hogan B L
In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2.
Development (Cambridge, England) 1990;110(2):609-20.
1990: Pelton R W; Hogan B L; Miller D A; Moses H L
Differential expression of genes encoding TGFs beta 1, beta 2, and beta 3 during murine palate formation.
Developmental biology 1990;141(2):456-60.
1990: Arteaga C L; Coffey R J; Dugger T C; McCutchen C M; Moses H L; Lyons R M
Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(8):367-74.
1990: Yang E Y; Moses H L
Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.
The Journal of cell biology 1990;111(2):731-41.
1990: Beauchamp R D; Lyons R M; Yang E Y; Coffey R J; Moses H L
Expression of and response to growth regulatory peptides by two human pancreatic carcinoma cell lines.
Pancreas 1990;5(4):369-80.
1990: Barnard J A; Lyons R M; Moses H L
The cell biology of transforming growth factor beta.
Biochimica et biophysica acta 1990;1032(1):79-87.
1990: Pietenpol J A; Stein R W; Moran E; Yaciuk P; Schlegel R; Lyons R M; Pittelkow M R; Münger K; Howley P M; Moses H L
TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains.
Cell 1990;61(5):777-85.
1990: Pietenpol J A; Holt J T; Stein R W; Moses H L
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(10):3758-62.
1990: Sipes N J; Miller D A; Bascom C C; Winkler J K; Matrisian L M; Moses H L
Altered regulation of protein disulfide isomerase in cells resistant to the growth-inhibitory effects of transforming growth factor beta 1.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1990;1(5):241-6.
1990: Torre-Amione G; Beauchamp R D; Koeppen H; Park B H; Schreiber H; Moses H L; Rowley D A
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.
Proceedings of the National Academy of Sciences of the United States of America 1990;87(4):1486-90.
1990: Miller D A; Pelton R W; Derynck R; Moses H L
Transforming growth factor-beta. A family of growth regulatory peptides.
Annals of the New York Academy of Sciences 1990;593():208-17.
1990: Sipes N J; Lyons R M; Moses H L
Isolation and characterization of Kirsten murine sarcoma virus-transformed mouse keratinocytes resistant to transforming growth factor beta.
Molecular carcinogenesis 1990;3(1):12-9.
1989: Graycar J L; Miller D A; Arrick B A; Lyons R M; Moses H L; Derynck R
Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.
Molecular endocrinology (Baltimore, Md.) 1989;3(12):1977-86.
1989: Miller D A; Lee A; Matsui Y; Chen E Y; Moses H L; Derynck R
Complementary DNA cloning of the murine transforming growth factor-beta 3 (TGF beta 3) precursor and the comparative expression of TGF beta 3 and TGF beta 1 messenger RNA in murine embryos and adult tissues.
Molecular endocrinology (Baltimore, Md.) 1989;3(12):1926-34.
1989: Bascom C C; Wolfshohl J R; Coffey R J; Madisen L; Webb N R; Purchio A R; Derynck R; Moses H L
Complex regulation of transforming growth factor beta 1, beta 2, and beta 3 mRNA expression in mouse fibroblasts and keratinocytes by transforming growth factors beta 1 and beta 2.
Molecular and cellular biology 1989;9(12):5508-15.
1989: Miller D A; Lee A; Pelton R W; Chen E Y; Moses H L; Derynck R
Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos.
Molecular endocrinology (Baltimore, Md.) 1989;3(7):1108-14.
1989: Skinner M K; Moses H L
Transforming growth factor beta gene expression and action in the seminiferous tubule: peritubular cell-Sertoli cell interactions.
Molecular endocrinology (Baltimore, Md.) 1989;3(4):625-34.
1989: Barnard J A; Beauchamp R D; Coffey R J; Moses H L
Regulation of intestinal epithelial cell growth by transforming growth factor type beta.
Proceedings of the National Academy of Sciences of the United States of America 1989;86(5):1578-82.
1989: Bascom C C; Sipes N J; Coffey R J; Moses H L
Regulation of epithelial cell proliferation by transforming growth factors.
Journal of cellular biochemistry 1989;39(1):25-32.
1988: Barnard J A; Bascom C C; Lyons R M; Sipes N J; Moses H L
Transforming growth factor beta in the control of epidermal proliferation.
The American journal of the medical sciences 1988;296(3):159-63.
1988: Coffey R J; Bascom C C; Sipes N J; Graves-Deal R; Weissman B E; Moses H L
Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta.
Molecular and cellular biology 1988;8(8):3088-93.
1988: Lyons R M; Keski-Oja J; Moses H L
Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium.
The Journal of cell biology 1988;106(5):1659-65.
1988: Keski-Oja J; Raghow R; Sawdey M; Loskutoff D J; Postlethwaite A E; Kang A H; Moses H L
Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-beta. Divergent responses in lung fibroblasts and carcinoma cells.
The Journal of biological chemistry 1988;263(7):3111-5.
1988: Coffey R J; Sipes N J; Bascom C C; Graves-Deal R; Pennington C Y; Weissman B E; Moses H L
Growth modulation of mouse keratinocytes by transforming growth factors.
Cancer research 1988;48(6):1596-602.
1988: Keski-Oja J; Blasi F; Leof E B; Moses H L
Regulation of the synthesis and activity of urokinase plasminogen activator in A549 human lung carcinoma cells by transforming growth factor-beta.
The Journal of cell biology 1988;106(2):451-9.
1988: Keski-Oja J; Postlethwaite A E; Moses H L
Transforming growth factors in the regulation of malignant cell growth and invasion.
Cancer investigation 1988;6(6):705-24.
1987: Keski-Oja J; Lyons R M; Moses H L
Immunodetection and modulation of cellular growth with antibodies against native transforming growth factor-beta 1.
Cancer research 1987;47(24 Pt 1):6451-8.
1987: Keski-Oja J; Leof E B; Lyons R M; Coffey R J; Moses H L
Transforming growth factors and control of neoplastic cell growth.
Journal of cellular biochemistry 1987;33(2):95-107.
1987: Moses H L; Coffey R J; Leof E B; Lyons R M; Keski-Oja J
Transforming growth factor beta regulation of cell proliferation.
Journal of cellular physiology. Supplement 1987;Suppl 5():1-7.

Sign-in to see more